A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood
Open Access
- 1 July 1997
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 76 (1) , 29-35
- https://doi.org/10.1038/bjc.1997.331
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-upBritish Journal of Cancer, 1994
- SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2International Journal of Cancer, 1994
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significanceEuropean Journal of Cancer and Clinical Oncology, 1991
- Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell LymphomaNew England Journal of Medicine, 1991
- Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reactionThe Lancet, 1991
- Access to a Messenger RNA Sequence or Its Protein Product Is Not Limited by Tissue or Species SpecificityScience, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Characterization of the Human Tumor and Normal Tissue Reactivity of the KS1/4 Monoclonal AntibodyHybridoma, 1988
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979